Search Results - "Janowski, W."

Response adaptive salvage treatment with daratumumab–lenalidomide–dexamethasone for newly diagnosed transplant‐eligible multiple myeloma patients failing front‐line bortezomib‐based induction therapy—ALLG MM21 by Lim, S., Reynolds, J., Quach, H., Hutchinson, A., Kerridge, I., Janowski, W., Bergin, K., Spencer, A.

“…Summary In Australia, bortezomib‐based induction (V‐IND) is used in >90% of newly diagnosed transplant‐eligible multiple myeloma (MM) patients. Four cycles of…”
Get full text

Glofitamab plus R‐CHOP or polatuzumab vedotin‐R‐CHP is deliverable with high overall response in patients ≤65 years of age with high‐risk DLBCL: Interim analysis of COALITION by Minson, A., Verner, E., Giri, P., Wong, S. M., Ratnasingam, S., Butler, J., Janowski, W., Ku, M., Cheah, C. Y., Hertzberg, M., Herbert, K., Hamad, N., Yannakou, C. K., Neeson, P., Saghebi, J., Blombery, P., Robertson, M., Lau, L. S., Xie, J., Seymour, J. F., Dickinson, M.

Get full text

Quantitative relationship of first metatarsophalangeal head morphology to hallux rigidus and hallux valgus by Michelson, James D., MD, Janowski, Jessie W., MD, Charlson, Mark D., MD

“…Highlights • Hallux rigidus metatarsal heads are quantitatively flatter than in hallux valgus. • Hallux rigidus metatarsal heads are less circular than in…”
Get full text

P30 SINGLE COHORT RESULTS FROM MAJESTEC‐2: TECLISTAMAB (TEC) IN COMBINATION WITH SUBCUTANEOUS DARATUMUMAB (DARA) AND LENALIDOMIDE (LEN) IN PATIENTS WITH MULTIPLE MYELOMA (MM) by Searle, E., Quach, H., Wong, S., Costa, L., Hulin, C., Janowski, W., Berdeja, J., Anguille, S., Matous, J., Touzeau, C., Michallet, A., Husnik, M., Vishwamitra, D., Niu, Z., Larsen, J., Chen, L., Goldberg, J., Popat, R., Spencer, A.

Get full text

P946: A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN, CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: AMARC 19‐02 BELACARD STUDY by Lasica, M., Spencer, A., Campbell, P., Wallington‐Gates, C., Wong Doo, N., Janowski, W., McCaughan, G., Puliyayil, A., Yuen, F., Le, K., Reynolds, J., Quach, H.

Get full text

Effects of selective and nonselective PGE2 receptor agonists on cervical tensile strength and collagen organization and microstructure in the pregnant rat at term by Feltovich, Helen, Ji, Huiling, Janowski, Jessie W., Delance, Nicole C., Moran, Colleen C., Chien, Edward K.

“…The purpose of this study was to determine which of the 4 PGE2 receptors (EP1-EP4) is involved in cervical ripening in the rat, and to correlate its activity…”
Get full text

Integrin Engagement Mediates the Human Polymorphonuclear Leukocyte Response to a Fungal Pathogen-Associated Molecular Pattern by Lavigne, Liz M, O'Brien, Xian M, Kim, Minsoo, Janowski, Jessie W, Albina, Jorge E, Reichner, Jonathan S

“…Extravasation of leukocytes from peripheral blood is required for an effective inflammatory response at sites of tissue infection. Integrins help mediate…”
Get full text

Multiple thrombotic events following warfarin reversal by Ratnaweera, M., Janowski, W., Simmons, D.

Get full text

P14: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA by Usmani, S, Alonso, A, Quach, H, Koh, Y, Guenther, A, Min, CK, Leleu, X, Abdallah, AO, Oriol, A, Bessemer, B, Garg, M, Sandhu, I, Weisel, K, Ocio San Miguel, E, Cavo, M, Zhou, X, Kaisermann, M, Mis, L, Williams, D, Yeakey, A, Ferron-Brady, G, Figueroa, D, Kremer, B, Gupta, I, Janowski, W

Get full text

P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA by Usmani, S. Z., Mielnik, M., Koh, Y., Alonso Alonso, A., Leleu, X., Quach, H., Min, C.-K., Janowski, W., Abdallah, A.-O., Garg, M., Sandhu, I., Ocio San Miguel, E. M., Oriol, A., Rodriquez-Otero, P., Ramasamy, K., Weisel, K., Besemer, B., Cavo, M., Zhou, X. L., Kaisermann, M. C., Bego Marques, C. M., Williams, D., Carreno, F., Kremer, B. E., Gupta, I. V., Hus, M.

Get full text

Anomalous Courses of the Palmar Cutaneous Branch of the Median Nerve in Relation to the Flexor Carpi Radialis Tendon for ORIF of Distal Radius Fractures by Glickel, Steven Z., Glynn, Sara M., Chang, Andy L., Janowski, Jessie W., Barron, O. Alton, Catalano, Louis W.

“…Background: The purpose of this study was to prospectively document the incidence of variations in the course of palmar cutaneous branch of the median nerve…”
Get full text

Zanubrutinib monotherapy for patients with treatment naïve chronic lymphocytic leukemia and 17p deletion by Tam, Constantine S, Robak, Tadeusz, Ghia, Paolo, Kahl, Brad S, Walker, Patricia, Janowski, Wojciech, Simpson, David, Shadman, Mazyar, Ganly, Peter S, Laurenti, Luca, Opat, Stephen, Tani, Monica, Ciepluch, Hanna, Verner, Emma, Šimkovič, Martin, Österborg, Anders, Trněný, Marek, Tedeschi, Alessandra, Paik, Jason C, Kuwahara, Sowmya B, Feng, Shibao, Ramakrishnan, Vanitha, Cohen, Aileen, Huang, Jane, Hillmen, Peter, Brown, Jennifer R

“…Patients with chronic lymphocytic leukemia or small lymphocytic lymphoma whose tumors carry deletion of chromosome 17p13.1 [del(17p)] have an unfavorable…”
Get full text

Efficacy and Safety of Zanubrutinib in Patients with Treatment-Naive Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) with Del(17p): Initial Results from Arm C of the Sequoia (BGB-3111-304) Trial by Tam, Constantine S., Robak, Tadeusz, Ghia, Paolo, Kahl, Brad S., Walker, Patricia, Janowski, Wojciech, Simpson, David, Shadman, Mazyar, Ganly, Peter S., Laurenti, Luca, Opat, Stephen, Tani, Monica, Ciepluch, Hanna, Verner, Emma, Simkovic, Martin, Österborg, Anders, Trněný, Marek, Tedeschi, Alessandra, Paik, Jason, Marimpietri, Carol, Feng, Shibao, Huang, Jane, Hillmen, Peter, Brown, Jennifer R.

“…Background: Patients with CLL/SLL whose tumor exhibits the deletion of chromosome 17p13.1 [del(17p)] have an unfavorable prognosis and respond poorly to…”
Get full text

P942: DREAMM‐9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT‐INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA by Usmani, S. Z., Mielnik, M., Koh, Y., Alonso Alonso, A., Leleu, X., Quach, H., Min, C.‐K., Janowski, W., Abdallah, A.‐O., Garg, M., Sandhu, I., Ocio San Miguel, E. M., Oriol, A., Rodriquez‐Otero, P., Ramasamy, K., Weisel, K., Besemer, B., Cavo, M., Zhou, X. L., Kaisermann, M. C., Bego Marques, C. M., Williams, D., Carreno, F., Kremer, B. E., Gupta, I. V., Hus, M.

Get full text

P14: DREAMM‐9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT‐INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA by Usmani, S, Alonso, A, Quach, H, Koh, Y, Guenther, A, Min, CK, Leleu, X, Abdallah, AO, Oriol, A, Bessemer, B, Garg, M, Sandhu, I, Weisel, K, Ocio San Miguel, E, Cavo, M, Zhou, X, Kaisermann, M, Mis, L, Williams, D, Yeakey, A, Ferron‐Brady, G, Figueroa, D, Kremer, B, Gupta, I, Janowski, W

Get full text

Discoveries as the origin of modern economic values by Janowski, Wit K.

Get full text

A facile synthesis of phthalideisoquinolines by decarboxylation of phthalidecarboxylates in the presence of imine methiodides by CHIEFARI, J, JANOWSKI, W. K, PRAGER, R. H

Get full text

Autocrine Regulation of Endothelial Cell Function by CAP37 by Hansen, Heather Anne, Tsikitis, Vassiliki L., Janowski, Jessie W., Lee, Connie, Pereira, Anne, Reichner, Jonathan S.

“…Objective Cationic antimicrobial peptide (CAP37, azurocidin) has been identified as the primary soluble mediator through which neutrophils (PMN) compromise…”
Get full text

Unusual rearrangements of 2-aroylimidoyl-2-phenylethylidene to 2,5-disubstituted oxazoles by Clark, Adrian D., Janowski, Wit K., Prager, Rolf H.

“…Flash vacuum pyrolysis of 2-aroyl-3-phenylisoxazol-5(2H)-ones leads to good yields of 2-aryl-4-phenyloxazoles, and smaller quantities of…”
Get full text

Zur Morphologie des Eiters verschiedenen Ursprungs by Janowski, W.

Get full text